| Title | Hormone Molecular Biology and Clinical Investigation |
| Abbreviation | Horm. Mol. Biol. Clin. Investig. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrinology, Diabetes and Metabolism (Q3); Medicine (miscellaneous) (Q3); Endocrinology (Q4); Molecular Biology (Q4) |
| h-index | 45 |
| Overall Rank/Ranking | 13804 |
| SCImago Journal Rank (SJR) | 0.399 |
| Impact Score | 1.34 |
| Publisher | Walter de Gruyter GmbH |
| Country | Germany |
| ISSN | 18681883, 18681891 |
| Best Quartile | Q3 |
| Coverage History | 2010-2025 |
Hormone Molecular Biology and Clinical Investigation is a journal covering the technologies/fields/categories related to Endocrinology, Diabetes and Metabolism (Q3); Medicine (miscellaneous) (Q3); Endocrinology (Q4); Molecular Biology (Q4). It is published by Walter de Gruyter GmbH. The overall rank of Hormone Molecular Biology and Clinical Investigation is 13804. According to SCImago Journal Rank (SJR), this journal is ranked 0.399. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 45. The best quartile for this journal is Q3.
The ISSN of Hormone Molecular Biology and Clinical Investigation journal is 18681883, 18681891. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Hormone Molecular Biology and Clinical Investigation is cited by a total of 244 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Hormone Molecular Biology and Clinical Investigation is 1.34, which is computed in 2025 as per its definition. Hormone Molecular Biology and Clinical Investigation IF is increased by a factor of 0.14 and approximate percentage change is 11.67% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Hormone Molecular Biology and Clinical Investigation is 1.34. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.34 |
| 2023 | 1.20 |
| 2022 | 1.12 |
| 2021 | 1.58 |
| 2020 | 2.25 |
| 2019 | 2.27 |
| 2018 | 2.28 |
| 2017 | 2.45 |
| 2016 | 2.99 |
| 2015 | 1.38 |
| 2014 | 0.29 |
Hormone Molecular Biology and Clinical Investigation has an h-index of 45. It means 45 articles of this journal have more than 45 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Hormone Molecular Biology and Clinical Investigation is 18681883, 18681891. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Hormone Molecular Biology and Clinical Investigation is 13804. According to SCImago Journal Rank (SJR), this journal is ranked 0.399. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.399 |
| 2023 | 0.356 |
| 2022 | 0.355 |
| 2021 | 0.487 |
| 2020 | 0.734 |
| 2019 | 0.783 |
| 2018 | 0.947 |
| 2017 | 1.021 |
| 2016 | 0.937 |
| 2015 | 0.410 |
| 2014 | 0.215 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 13804 |
| 2023 | 14138 |
| 2022 | 13567 |
| 2021 | 10247 |
| 2020 | 6717 |
| 2019 | 6082 |
| 2018 | 4703 |
| 2017 | 4235 |
| 2016 | 4815 |
| 2015 | 10710 |
| 2014 | 16388 |
Hormone Molecular Biology and Clinical Investigation is published by Walter de Gruyter GmbH. It's publishing house is located in Germany. Coverage history of this journal is as following: 2010-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Hormone Molecular Biology and Clinical Investigation is Horm. Mol. Biol. Clin. Investig.. This abbreviation ('Horm. Mol. Biol. Clin. Investig.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrinology, Diabetes and Metabolism (Q3); Medicine (miscellaneous) (Q3); Endocrinology (Q4); Molecular Biology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Hormone Molecular Biology and Clinical Investigation latest impact IF is 1.34. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.99 (2016) and 0.29 (2014), respectively, in the last 11 years. Moreover, its average IS is 1.74 in the previous 11 years.
The Hormone Molecular Biology and Clinical Investigation has an SJR (SCImago Journal Rank) of 0.399, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.021 in 2017 and the lowest being 0.215 in 2014. Furthermore, the average SJR of the Hormone Molecular Biology and Clinical Investigation over the previous 11-year period stands at 1.74.
The latest h-index of the Hormone Molecular Biology and Clinical Investigation is 45.
The Hormone Molecular Biology and Clinical Investigation is published by the Walter de Gruyter GmbH, with its country of publication being the Germany.
The Hormone Molecular Biology and Clinical Investigation is currently ranked 13804 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 4235 in 2017 and its lowest position of 16388 in 2014.
The standard ISO4 abbreviation for the Hormone Molecular Biology and Clinical Investigation is Horm. Mol. Biol. Clin. Investig..
Hormone Molecular Biology and Clinical Investigation is classified as a journal that the Walter de Gruyter GmbH publishes.
The Hormone Molecular Biology and Clinical Investigation encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Hormone Molecular Biology and Clinical Investigation is assigned the following International Standard Serial Numbers (ISSN): 18681883, 18681891.
The best quartile for the Hormone Molecular Biology and Clinical Investigation is Q3 (2024).
The Hormone Molecular Biology and Clinical Investigation coverage history can be summarized as follows: 2010-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Historia | journal | 22470 | Universidade Estadual Paulista | 9 | 0.16 |
| Current Sociology | journal | 5151 | SAGE Publications Ltd | 86 | 3.02 |
| Milan Journal of Mathematics | journal | 5131 | Birkhauser Verlag Basel | 31 | 0.74 |
| Journal of Classical Sociology | journal | 16960 | SAGE Publications Ltd | 31 | 0.68 |
| Natural Solutions | trade journal | 28581 | Innovision Health Media | 1 | 0.00 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| English Literary Renaissance | journal | 29995 | University of Chicago Press | 23 | 0.24 |
| Revista Brasileira de Educacao Especial | journal | 20616 | Associacao Brasileira de Pesquisadores em Educacao Especial | 14 | 0.20 |
| Brazilian Journal of Physical Therapy | journal | 5241 | Revista Brasileira de Fisioterapia | 56 | 3.05 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.34 |
| 2023 | 1.20 |
| 2022 | 1.12 |
| 2021 | 1.58 |
| 2020 | 2.25 |
| 2019 | 2.27 |
| 2018 | 2.28 |
| 2017 | 2.45 |
| 2016 | 2.99 |
| 2015 | 1.38 |
| 2014 | 0.29 |
